Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €1.18 EUR
Change Today +0.027 / 2.35%
Volume 7.2K
NN6 On Other Exchanges
As of 1:36 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

nanorepro ag (NN6) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/29/15 - €1.86
52 Week Low
01/9/15 - €0.62
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NANOREPRO AG (NN6)

Related News

No related news articles were found.

nanorepro ag (NN6) Related Businessweek News

No Related Businessweek News Found

nanorepro ag (NN6) Details

NanoRepro AG develops, manufactures, and markets rapid diagnostics for domestic use. The company offers Heli-C CHECK, a method for the detection of the bacterium Helicobacter pylori, which is present in the human gastrointestinal tract that causes various stomach diseases; FertiQUICK, an in-pharmacy fertility test for men; and GlutenCHECK, a test that a consumer can identify celiac disease, an intolerance to grain protein at home. It also provides OvuQUICK, an ovulation test showing when the chance of becoming pregnant is greatest; VagiQUICK, a vaginal fungal test for the detection of Candida albicans; and GraviQUICK, a pregnancy test to determine whether they are pregnant 10 days after intercourse. In addition, the company offers MenoQUICK that allows women to determine whether they have entered menopause using the tape test method; CholesterinCHECK, which measures total cholesterol; AlkoholTEST, an alcohol breath detector test; and FOBCHECK, a self test that detects any hidden blood in stool, which can be an early sign of diseases, such as intestinal polyps or colorectal cancer. NanoRepro AG is headquartered in Marburg, Germany.

nanorepro ag (NN6) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanorepro ag (NN6) Key Developments

NanoRepro AG Signs Distribution Agreement for Romania, Moldova

NanoRepro AG announced that it has signed a three-year exclusive distribution agreement with an east-European partner for the regions of Romania and Moldova. The company expects combined revenues of some €450,000 ($513,000) by 2018.

NanoRepro AG, Annual General Meeting, Jul 02, 2015

NanoRepro AG, Annual General Meeting, Jul 02, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NN6:GR €1.18 EUR +0.027

NN6 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NN6.
View Industry Companies

Industry Analysis


Industry Average

Valuation NN6 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOREPRO AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at